Healthcare, biotechnology & medical AI Product
Cleerly Labs and Cleerly ISCHEMIA have distinct coronary CT roles
Cleerly Labs presents quantitative and visual information from coronary CT angiography. Cleerly ISCHEMIA has a separate clearance for adjunctive information about likely ischemia. [1][2]
What it does
The FDA cleared Cleerly Labs on November 5, 2019, under K190868 and the cited Cleerly ISCHEMIA submission on October 29, 2026, under K262839. [1][2]
Why it matters
The two filings distinguish measurements of coronary anatomy and plaque from an adjunctive assessment based on those measurements and other image-derived information. [1][2]
Who it’s for
The specified outputs support trained professionals interpreting coronary imaging and the related analysis. [1][2]
Key dates
Where it fits
The Labs filing describes visual and quantitative review. The ISCHEMIA filing names a separate add-on module used with a later Cleerly Labs configuration. [1][2]
Limits and trade-offs
The 2026 filing refers to a specific later host configuration. The 2019 Labs clearance has its own scope. [1][2]
Sources and verification
Catalog evidence checked How we verify records
- Primary source FDA 510(k) decision for Cleerly ISCHEMIA (K262839)
- Primary source FDA 510(k) decision for Cleerly Labs (K190868)
Related profiles
Healthcare, biotechnology & medical AI
Sleep Analysis Module (SAM)
Neurotronics (Nihon Kohden)
The module estimates sleep time from a signal captured during its intended sleep-testing workflow.
Healthcare, biotechnology & medical AI
Heartvue.Proton
Heartvue.ai
It is software for analyzing cardiac MRI images within its documented intended-use scope.
Healthcare, biotechnology & medical AI
ThinkSono Guidance
ThinkSono
Provides guidance during acquisition of lower-extremity compression ultrasound images for review by healthcare professionals.